Citalopram at the recommended human doses after long-term treatment is genotoxic for male germ cell

Food and Chemical Toxicology

Volumn 53, Issue , 2013, Pages 281-285

  Attia, Sabry M ^a,b   Bakheet, Saleh A ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Al Azhar University   (Egypt)

Author keywords

Antidepressants; Citalopram; Genotoxicity; Germ cells; Oxidative DNA damage

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CITALOPRAM; CYCLOPHOSPHAMIDE; DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA STRAND BREAKAGE; DRUG DOSE COMPARISON; DRUG EXPOSURE; GENOTOXICITY; GERM CELL; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; RECOMMENDED DRUG DOSE; REPRODUCTIVE TOXICITY; SEMEN ANALYSIS; SINGLE DRUG DOSE; SPERMATOCYTE; TREATMENT DURATION;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; COMET ASSAY; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; SPERMATOCYTES; TIME FACTORS;

MUS;

EID: 84872191874     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2012.11.051     Document Type: Article

References (37)

1. Abdelmajeed N.A. Oxidative tissue damage induced by citalopram in rat different organs. Res. J. Med. Med. Sci. 2009, 4(2):580-586.
2. Adler I.D. Cytogenetic tests in mammals. Mutagenicity Testing - A Practical Approach 1984, 275-306. IRL Press, Oxford. S. Venitt, J.M. Parry (Eds.).
3. Aitken R.J., Baker M.A. Oxidative stress and male reproductive biology. Reprod. Fertil. Dev. 2004, 16:581-588.
4. Attia S.M. Mutagenicity of some topoisomerase II-interactive agents. SPJ 2008, 17(1):1-24.
5. Attia S.M. Deleterious effects of reactive metabolites. Oxid. Med. Cell. Longev. 2010, 3(4):238-253.
6. Attia S.M. Influence of resveratrol on genomic damage induced by cisplatin. Mutat. Res. 2012, 741(1-2):22-31.
7. Attia S.M., Badary O.A., Hamada F.M., de Angelis M. Hrabé, Adler I.D. Orthovanadate increased the frequency of aneuploid mouse sperm without micronucleus induction in mouse bone marrow erythrocytes at the same dose level. Mutat. Res. 2005, 583(2):158-167.
8. Attia S.M., Badary O.A., Hamada F.M., de Angelis M. Hrabé, Adler I.D. The chemotherapeutic agents nocodazole and amsacrine cause meiotic delay and non-disjunction in spermatocytes of mice. Mutat. Res. 2008, 651(1-2):105-113.
9. Attia S.M., Bakheet S.A., Al-Rasheed N.M. Proanthocyanidins produce significant attenuation of doxorubicin-induced mutagenicity via suppression of oxidative stress. Oxid. Med. Cell. Longev. 2010, 3(6):404-413.
10. Brambilla G., Mattioli F., Martelli A. Genotoxic and carcinogenic effects of antipsychotics and antidepressants. Toxicology 2009, 261(3):77-88.
11. Brandes L.J., Arron R.J., Bogdanovic R.P., Tong J., Zaborniak C.L., Hogg G.R., Warrington R.C., Fang W., LaBella F.S. Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. Cancer Res. 1992, 52(13):3796-3800.
12. Bungum M., Humaidan P., Axmon A., Spano M., Bungum L., Erenpreiss J., Giwercman A. Sperm DNA integrity assessment in prediction of assisted reproduction technology outcome. Hum. Reprod. 2007, 22:174-179.
13. Collins J.A., Barnhart K.T., Schlegel P.N. Do sperm DNA integrity tests predict pregnancy with in vitro fertilization?. Fertil. Steril. 2008, 89:823-831.
14. Evenson D.P., Jost L.K., Marshall D., Zinaman M.J., Clegg E., Purvis K., de Angelis P., Claussen O.P. Utility of the sperm chromatin structure assay (SCSA) as a diagnostic and prognostic tool in the human fertility clinic. Hum. Reprod. 1999, 14:1039-1049.
15. Floyd R.A. The role of 8-hydroxyguanine in carcinogenesis. Carcinogenesis 1990, 11:1447-1450.
16. Hendrick V., Gitlin M., Althshuler L., Korenman S. Antidepressant medications, mood and male fertility. Psychoneuroendocrinology 2000, 25:37-51.
17. Hilakivi-Clarke L.A., Arora P.K., Clarke R., Wright A., Lippman M.E., Dickson R.B. Opposing behavioural alterations in male and female transgenic TGF alpha mice: association with tumour susceptibility. Br. J. Cancer 1993, 67(5):1026-1030.
18. IMS Health, 2008. IMS National Prescription Audit Plus. (Last accessed 02.11.08). http://www.imshealth.com/portal/site/imshealth.
19. Kaneko T., Tahara S., Matsuo M. Non-linear accumulation of 8-hydroxy-2'-deoxyguanosine, a marker of oxidized DNA damage, during aging. Mutat. Res. 1996, 316:277-285.
20. Moorman P.G., Grubber J.M., Millikan R.C., Newman B. Antidepressant medications and their association with invasive breast cancer and carcinoma in situ of the breast. Epidemiology 2003, 14(3):307-314.
21. National Institute of Mental Health, 2009. Depression in men. Available at: (Last accessed 02.01.09). http://www.nimh.nih.gov/health/topics/depression/men-and-depression/depression-in-men.shtml.
22. Palo A.K., Sahoo D., Choudhury R.C. Cytosine arabinoside-induced cytogenotoxicity in bone marrow and spermatogonial cells of mice and its potential transmission through the male germline. Mutat. Res. 2009, 673(1):29-36.
23. Pollock B.G. Citalopram: a comprehensive review. Expert Opin. Pharmacother. 2001, 2(4):681-698.
24. Racevskis, J., 2005. Molecular diagnosis of cancer: methods and protocols, second ed. Med. Oncol. 22, pp. 325-326.
25. Ramos L., Kleingeld P., Meuleman E., van Kooy R., Kremer J., Braat D., Wetzels A. Assessment of DNA fragmentation of spermatozoa that were surgically retrieved from men with obstructive azoospermia. Fertil. Steril. 2002, 77:233-237.
26. Safarinejad M.R. Sperm DNA damage and semen quality impairment after treatment with selective serotonin reuptake inhibitors detected using semen analysis and sperm chromatin structure assay. J. Urol. 2008, 180(5):2124-2128.
27. Saleh R.A., Agarwal A., Nelson D.R., Nada E.A., El-Tonsy M.H., Alvarez J.G., Thomas A.J., Sharma R.K. Increased sperm nuclear DNA damage in normozoospermic infertile men: a prospective study. Fertil. Steril. 2002, 78:313-318.
28. Shen H., Ong C. Detection of oxidative DNA damage in human sperm and its association with sperm function and male infertility. Free Radical Biol. Med. 2000, 28:529-536.
29. Sikka S.C. Relative impact of oxidative stress on male reproductive function. Curr. Med. Chem. 2001, 8:851-862.
30. Singh N.P., Muller C.H., Berger R.E. Effects of age on DNA double-strand breaks and apoptosis in human sperm. Fertil. Steril. 2003, 80(6):1420-1430.
31. Sloot W.N., Bowden H.C., Yih T.D. In vitro and in vivo reproduction toxicology of monoaminergic reuptake inhibitors: possible mechanisms of infrequent cardiovascular anomalies. Reprod. Toxicol. 2009, 28(2):270-282.
32. Steingart A., Cotterchio M., Kreiger N., Sloan M. Antidepressant medication use and breast cancer risk: a case-control study. Int. J. Epidemiol. 2003, 32(6):961-966.
33. Sun F., Ko E., Martin R.H. Is there a relationship between sperm chromosome abnormalities and sperm morphology?. Reprod. Biol. Endocrinol. 2006, 4:1.
34. Tanrikut C., Schlegel P.N. Antidepressant-associated changes in semen parameters. Urology 2007, 69(1):185.e5-185.e7.
35. Waldinger M.D., Zwinderman A.H., Olivier B. SSRIs and ejaculation: a double-blind, randomized, fixed-dose study with paroxetine and citalopram. J. Clin. Psychopharmacol. 2001, 21:556-560.
36. World Health Organisation WHO Laboratory Manual for the Examination of Human Semen Samples and Sperm-Cervical Mucus Interaction 1992, Press Syndicate of the University of Cambridge, Cambridge, UK, pp. 23-27. third ed.
37. Wyrobek A.J., Bruce W.R. Chemical induction of sperm abnormalities in mice. Proc. Natl. Acad. Sci. USA 1975, 72:4425-4429.